Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
NIGHTINGALE HEALTH EO 1
7XENightingale Health Oyj, a health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Health Check Remote where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has research collaboration agreement with ZOE Limited for its blood collection device. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland. Address: Mannerheimintie 164a, Helsinki, Finland, 00300
Analytics
Zielpreis von Wall Street
1.2 EURKGV
–Dividendenrendite
–Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 7XE
Dividenden-Analyse 7XE
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
–Verlauf der Dividende 7XE
Bewertung der Aktie 7XE
Finanzen 7XE
Ergebnisse | 2019 | Dynamik |